
Editor-in-Chief: Song Guo Zheng; Yanling Hu
Acceptance: 10%
Final Decision: 1 week
APC: 0
About the Journal
iCell is a newly established, peer-reviewed journal dedicated to the dissemination of cutting-edge research in cellular biology. The journal focuses on innovative studies that advance our understanding of cellular processes, mechanisms, and applications in medicine and biotechnology.
Current Issue
Pan-cancer phosphoproteomics identifies pervasive hyperphosphorylation of RNA-binding proteins as a core driver of tumor RNA dysfunction. This study pinpoints NCL T76 phosphorylation as a conserved prognostic risk signal across multiple cancers, controlled by CDK2 kinase. The small-molecule inhibitor TG-02 suppresses NCL T76 phosphorylation, revealing the CDK2–NCL T76 axis as a promising therapeutic target for solid tumors. Image credit: Cover article.